US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AN2 Therapeutics, Inc.

1.29

+0.02001.57%

Volume:30.28K

Turnover:38.16K

Market Cap:38.83M

PE:-0.75

High:1.31

Open:1.26

Low:1.24

Close:1.27

Loading ...

Overview Company News Filings

AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI

AN2 Therapeutics, Inc.: Promising Future with Strong Financial Health and Strategic Advancements

AN2 Therapeutics Q4 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate

AN2 Therapeutics: Anticipated to Fund Operations Through 2027 Under Current Strategic Plan

THOMSON REUTERS

AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

THOMSON REUTERS

AN2 Therapeutics Q4 Net Income USD -7.522 Million

THOMSON REUTERS

Press Release: AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

Calendar of U.S. Earnings Expected in the Week Ahead

AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference

Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)

Golden Sun Health Technology Group Leads 3 US Penny Stocks Worth Monitoring

Simply Wall St.

AN2 Therapeutics Price Target Maintained With a $5.00/Share by Citizens Capital Markets

BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung Disease

AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease

THOMSON REUTERS

AN2 Therapeutics Inc: to Release Topline Phase 3 Results for Ebo-301 in Q2 of 2025

THOMSON REUTERS

AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease

AN2 Therapeutics to Participate at Upcoming Investor Conferences

AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities

Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics Price Target Maintained With a $5.00/Share by JMP Securities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ANTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":1.29,"timestamp":1745524800000,"preClose":1.27,"halted":0,"volume":30278,"delay":0,"floatShares":17669814,"shares":30098720,"eps":-1.720551,"marketStatus":"Pre-Mkt","change":0.02,"latestTime":"04-25 05:07:44 EDT","open":1.26,"high":1.31,"low":1.24,"amount":38156.2066,"amplitude":0.055118,"askPrice":1.5,"askSize":100,"bidPrice":1.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.720551,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":1.29,"postHourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.29,"latestTime":"16:05 EDT","volume":1,"amount":1.29,"timestamp":1745525109594},"volumeRatio":1.1116006270637602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":17669814,"roa":"-29.54%","roe":"-49.69%","lyrEps":-1.720551,"volumeRatio":1.1116006270637602,"shares":30098720,"dividePrice":2.625,"high":1.31,"amplitude":0.055118,"preClose":1.27,"low":1.24,"week52Low":0.87,"pbRate":"0.47","week52High":3.07,"institutionHeld":0,"latestPrice":1.29,"eps":-1.720551,"divideRate":2.034884,"volume":30278,"delay":0,"ttmEps":-1.720551,"open":1.26,"prevYearClose":1.38,"prevWeekClose":1.26,"prevMonthClose":1.36,"prevQuarterClose":1.36,"fiveDayClose":1.28,"twentyDayClose":1.52,"sixtyDayClose":1.23},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524130755","title":"AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2524130755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524130755?lang=en_us&edition=fundamental","pubTime":"2025-04-01 13:56","pubTimestamp":1743486981,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) yesterday and set a price target of $2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2522282893","title":"AN2 Therapeutics, Inc.: Promising Future with Strong Financial Health and Strategic Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2522282893","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522282893?lang=en_us&edition=fundamental","pubTime":"2025-03-26 12:25","pubTimestamp":1742963113,"startTime":"0","endTime":"0","summary":"Analyst Roy Buchanan of JMP Securities reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report), retaining the price target of $5...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/an2-therapeutics-inc-promising-future-with-strong-financial-health-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/an2-therapeutics-inc-promising-future-with-strong-financial-health-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522874538","title":"AN2 Therapeutics Q4 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522874538","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522874538?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:06","pubTimestamp":1742933177,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 56.14 percent increase over losses of $(0.57) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481284/an2-therapeutics-q4-2024-gaap-eps-0-25-beats-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ANTX"],"gpt_icon":0},{"id":"2522887512","title":"AN2 Therapeutics: Anticipated to Fund Operations Through 2027 Under Current Strategic Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887512?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA22Z1D1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522887379","title":"AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887379?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA22Z1D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522887372","title":"AN2 Therapeutics Q4 Net Income USD -7.522 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887372?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLXEEEB5D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2522887324","title":"Press Release: AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887324?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932800,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights. Phase 3 topline data expected 2Q25 for epetraborole in patients with treatment-refractory MAC lung disease . Phase 1 first in human study of AN2-502998, under development for Chagas disease, to start mid-2025 in healthy volunteers. Topline data for melioidosis observational trial expected in 2Q25; Phase 2 epetraborole study planned for 2H25. Cash, cash equivalents, and investments of $88.6 million at December 31, 2024 anticipated to fund operations through 2027 under current strategic plan. In February 2025, the Company submitted an amended statistical analysis plan to the FDA selecting the Quality of Life -- Bronchiectasis  respiratory domain patient reported outcome  instrument as the primary efficacy endpoint for the Phase 3 part of the EBO-301 trial. The Company believes that this approach aligns with current FDA Guidance for Industry on NTM drug development r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4023","ANTX","LENZ","BK4007","PRO"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTAS","RVPH","SLRN","MREO","ANTX","THRD","BCAB","MDAI","PDSB","UNCY","CHWY","CDLR","SURG","KOD","AFMD","IVA","DERM","CNXC","WGO","IKT","WBA","LPTX","ZURA","ALUR","PAYX","ABL","CRMD","NUTX","TEN","FBIO","MLKN","SDST","PAYS","IOBT","CALC","BEEM","MKC","OBIO","SKYX","SCS","RLMD","WOOF","GRDN","GOVX","KBH","DLTR","EDAP","XFOR","CLSD","ACRV"],"gpt_icon":0},{"id":"2516666305","title":"AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666305","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666305?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:00","pubTimestamp":1741035600,"startTime":"0","endTime":"0","summary":"Eric Easom, Co-Founder, Chairman, President and CEO, will provide a corporate overview on Wednesday, March 12, 2025 at 2:20 pm ET, and members of management will be available for 1X1 meetings.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-present-leerink-partners-210000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4137","BK4007","LENZ","HCSG","ANTX"],"gpt_icon":0},{"id":"2514000870","title":"Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514000870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514000870?lang=en_us&edition=fundamental","pubTime":"2025-02-26 13:45","pubTimestamp":1740548736,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) yesterday and set a price target of $2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-reaffirms-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-reaffirms-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX"],"gpt_icon":0},{"id":"2514904689","title":"Golden Sun Health Technology Group Leads 3 US Penny Stocks Worth Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904689","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904689?lang=en_us&edition=fundamental","pubTime":"2025-02-26 04:11","pubTimestamp":1740514312,"startTime":"0","endTime":"0","summary":"As the S&P 500 and Nasdaq Composite continue to experience declines, investor sentiment is being tested by economic uncertainties and fluctuating market conditions. Despite these challenges, penny stocks remain a notable segment for investors seeking opportunities in smaller or newer companies. While the term \"penny stocks\" may seem outdated, it still encapsulates firms that have the potential for growth when backed by strong financials. In this context, certain penny stocks are emerging as intriguing options for those interested in exploring under-the-radar investments with promising prospects.Click here to see the full list of 728 stocks from our US Penny Stocks screener.Overview: Golden Sun Health Technology Group Limited operates in China, offering education services related to medical health, e-commerce live broadcasting, and cultural and tourism services, with a market cap of $5.25 million.Get an in-depth perspective on Golden Sun Health Technology Group's performance by reading ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/golden-sun-health-technology-group-201152293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4021","NRT","BK4204","BABB","BK4209","NTWK","ANTX","BK4007","BK4563","BK4213","SB","PHX","PVL","GSUN"],"gpt_icon":0},{"id":"2514016442","title":"AN2 Therapeutics Price Target Maintained With a $5.00/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514016442?lang=en_us&edition=fundamental","pubTime":"2025-02-25 23:42","pubTimestamp":1740498120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 10:42 ET (15:42 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ANTX"],"gpt_icon":0},{"id":"2513729385","title":"BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729385","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513729385?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:24","pubTimestamp":1740403466,"startTime":"0","endTime":"0","summary":"BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung DiseaseFeb 24 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 PROVIDES STRATEGIC UPDATE FOR PHASE 3 EBO-301 T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2513740698","title":"AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740698?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2513402728","title":"AN2 Therapeutics Inc: to Release Topline Phase 3 Results for Ebo-301 in Q2 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513402728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513402728?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2513772808","title":"AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772808","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513772808?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"AN2 Selects QOL-B as New Phase 3 Primary Efficacy Endpoint. Goal to Accelerate Unblinding Phase 3 Data in Q2 2025 Ahead of Potential FDA Meeting. \"In Phase 2, we observed potentially meaningful clinical improvement in a highly refractory population. The FDA has made it clear that the primary bar for NTM drug approval is patient-reported improvement in NTM symptoms. Our recent statistical analysis plan submission provides the opportunity to seek FDA input on our selection of QOL-B as the new primary efficacy endpoint prior to unblinding the Phase 3 data and requesting a formal meeting,\" said Eric Easom, Co-Founder, President and Chief Executive Officer. \"Should the Phase 3 data confirm the Phase 2 findings, we plan to meet with the FDA to discuss potential registrational pathways in this highly refractory population with minimal to no treatment options.\". FDA’s 2023 Guidance for Industry on NTM drug development recommends PRO-based clinical outcome measures as the primary efficacy endpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-provides-strategic-phase-3-120000435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAC","BK4080","ANTX","BK4231","BK4007","BK4023","BK4551","PRO"],"gpt_icon":0},{"id":"2512044915","title":"AN2 Therapeutics to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2512044915","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512044915?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:00","pubTimestamp":1740052800,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., February 20, 2025----AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that company management will participate in two upcoming investor conferences in March.Eric Easom, Co-Founder, Chairman, President and CEO will provide a corporate overview on Monday, March 3, 2025 at 2:30 pm ET, and members of management will be available for 1X1 meetings.Members of management will be available for 1X1 meetings on Wednesday, March 12, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-participate-upcoming-investor-120000325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4007","BK4139","ANTX"],"gpt_icon":0},{"id":"2512495268","title":"AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2512495268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512495268?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:05","pubTimestamp":1740031520,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Roy Buchanan reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report) today and set a price target of $5.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-gets-a-buy-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-gets-a-buy-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX","BK4127","BK4007","JMP"],"gpt_icon":0},{"id":"2510820135","title":"Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510820135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510820135?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:36","pubTimestamp":1739255786,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX"],"gpt_icon":0},{"id":"2508459131","title":"AN2 Therapeutics Price Target Maintained With a $5.00/Share by JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2508459131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508459131?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:06","pubTimestamp":1738591560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 03, 2025 09:06 ET (14:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","JMP","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.6,"sell":0.2,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":5,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2025-04-24","current":-0.744829,"percent":0.787634,"low":-16.371108,"twenty":-8.48965,"median":-4.562154,"eighty":-0.7331,"high":-0.452319,"avg":-4.843746,"sd":3.941777,"marketCap":38225374},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.921625,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":60851241},{"date":"2024-06-07","current":-0.944214,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":62342693},{"date":"2024-06-14","current":-0.899037,"twenty":-9.612945,"median":-6.014805,"eighty":-2.882965,"marketCap":59359789},{"date":"2024-06-21","current":-0.935179,"twenty":-9.600596,"median":-5.975902,"eighty":-2.800663,"marketCap":61746112},{"date":"2024-06-28","current":-1.007463,"twenty":-9.593379,"median":-5.954462,"eighty":-2.72642,"marketCap":66518759},{"date":"2024-07-05","current":-1.224316,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":80836698},{"date":"2024-07-12","current":-1.147514,"twenty":-9.548809,"median":-5.8326,"eighty":-2.429778,"marketCap":75765761},{"date":"2024-07-15","current":-1.165585,"twenty":-9.542228,"median":-5.832059,"eighty":-2.4146,"marketCap":76958923},{"date":"2024-08-02","current":-1.152032,"twenty":-9.535646,"median":-5.831517,"eighty":-2.400893,"marketCap":76064052},{"date":"2024-08-09","current":-1.192692,"twenty":-9.469258,"median":-5.810078,"eighty":-2.273291,"marketCap":78748665},{"date":"2024-08-16","current":-0.47057,"twenty":-9.449136,"median":-5.779362,"eighty":-2.170214,"marketCap":30425620},{"date":"2024-08-23","current":-0.51232,"twenty":-9.447843,"median":-5.727894,"eighty":-2.006011,"marketCap":33125098},{"date":"2024-08-30","current":-0.521551,"twenty":-9.44504,"median":-5.717174,"eighty":-1.838033,"marketCap":33721947},{"date":"2024-09-06","current":-0.475396,"twenty":-9.437737,"median":-5.688753,"eighty":-1.659612,"marketCap":30737703},{"date":"2024-09-13","current":-0.480012,"twenty":-9.395084,"median":-5.681125,"eighty":-1.602796,"marketCap":31036128},{"date":"2024-09-20","current":-0.498474,"twenty":-9.366592,"median":-5.652855,"eighty":-1.557942,"marketCap":32229825},{"date":"2024-09-27","current":-0.486935,"twenty":-9.361608,"median":-5.599013,"eighty":-1.524052,"marketCap":31483764},{"date":"2024-10-04","current":-0.480012,"twenty":-9.336776,"median":-5.546792,"eighty":-1.494379,"marketCap":31036128},{"date":"2024-10-11","current":-0.480012,"twenty":-9.293554,"median":-5.527793,"eighty":-1.485178,"marketCap":31036128},{"date":"2024-10-18","current":-0.475396,"twenty":-9.271899,"median":-5.50278,"eighty":-1.463249,"marketCap":30737703},{"date":"2024-10-25","current":-0.493858,"twenty":-9.268418,"median":-5.485925,"eighty":-1.404343,"marketCap":31931401},{"date":"2024-10-31","current":-0.503089,"twenty":-9.245776,"median":-5.467741,"eighty":-1.384784,"marketCap":32528249},{"date":"2024-11-08","current":-0.507705,"twenty":-9.191651,"median":-5.440937,"eighty":-1.238642,"marketCap":32826674},{"date":"2024-11-15","current":-0.491662,"twenty":-9.159176,"median":-5.335911,"eighty":-1.189981,"marketCap":29842431},{"date":"2024-11-22","current":-0.604745,"twenty":-9.137345,"median":-5.292741,"eighty":-1.17212,"marketCap":36706190},{"date":"2024-11-29","current":-0.822079,"twenty":-9.095067,"median":-5.266277,"eighty":-1.154743,"marketCap":49897746},{"date":"2024-12-06","current":-0.713781,"twenty":-9.047317,"median":-5.253045,"eighty":-1.141948,"marketCap":43324390},{"date":"2024-12-13","current":-0.728549,"twenty":-9.004017,"median":-5.218642,"eighty":-1.13436,"marketCap":44220757},{"date":"2024-12-20","current":-0.625174,"twenty":-8.946955,"median":-5.18424,"eighty":-1.117586,"marketCap":37946190},{"date":"2024-12-27","current":-0.679323,"twenty":-8.795687,"median":-5.159815,"eighty":-1.10594,"marketCap":41232868},{"date":"2025-01-03","current":-0.684246,"twenty":-8.764395,"median":-5.131312,"eighty":-1.091686,"marketCap":41531657},{"date":"2025-01-10","current":-0.639942,"twenty":-8.756375,"median":-5.109656,"eighty":-1.077369,"marketCap":38842557},{"date":"2025-01-17","current":-0.625174,"twenty":-8.753654,"median":-5.065153,"eighty":-1.025534,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.743176,"median":-5.054567,"eighty":-1.007463,"marketCap":37348612},{"date":"2025-01-31","current":-0.575948,"twenty":-8.706848,"median":-5.044823,"eighty":-0.965899,"marketCap":34958301},{"date":"2025-02-07","current":-0.541489,"twenty":-8.666805,"median":-5.038689,"eighty":-0.946021,"marketCap":32866779},{"date":"2025-02-14","current":-0.526721,"twenty":-8.652374,"median":-5.00164,"eighty":-0.932468,"marketCap":31970412},{"date":"2025-02-21","current":-0.556257,"twenty":-8.638152,"median":-4.986004,"eighty":-0.918011,"marketCap":33763145},{"date":"2025-02-28","current":-0.546412,"twenty":-8.61494,"median":-4.906371,"eighty":-0.89994,"marketCap":33165567},{"date":"2025-03-07","current":-0.635019,"twenty":-8.592106,"median":-4.890493,"eighty":-0.87193,"marketCap":38543768},{"date":"2025-03-14","current":-0.694091,"twenty":-8.587408,"median":-4.858736,"eighty":-0.767931,"marketCap":42129234},{"date":"2025-03-21","current":-0.718704,"twenty":-8.568081,"median":-4.787284,"eighty":-0.729534,"marketCap":43623179},{"date":"2025-03-28","current":-0.838362,"twenty":-8.559336,"median":-4.763467,"eighty":-0.729534,"marketCap":43025601},{"date":"2025-04-04","current":-0.821071,"twenty":-8.531837,"median":-4.710422,"eighty":-0.734457,"marketCap":42138208},{"date":"2025-04-11","current":-0.70964,"twenty":-8.523283,"median":-4.675853,"eighty":-0.729459,"marketCap":36419451},{"date":"2025-04-17","current":-0.750694,"twenty":-8.50578,"median":-4.652166,"eighty":-0.7331,"marketCap":38526361},{"date":"2025-04-24","current":-0.744829,"twenty":-8.48965,"median":-4.562154,"eighty":-0.7331,"marketCap":38225374}],"updateTime":1745570604477}}}